Virpax Pharmaceuticals, Inc. (VRPX) has a consensus analyst rating of Hold, based on 1 analyst covering the stock. Of those, 0 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for VRPX is $3.00, representing a +599,900.0% upside from the current price of $0.0005. Price targets range from a low of $3.00 to a high of $3.00.
